Search Results

INTERNATIONAL PATENT: SPHINGOTEC GMBH, ADRENOMED AG FILES APPLICATION FOR "PRO-ADRENOMEDULLIN OR FRAGMENT THEREOF IN PATIENTS INFECTED WITH CORONA VIRUS AND TREATMENTS WITH BINDER AGAINST ADRENOMEDULLIN"

• Source: US Fed News (USA), November 27, 2021, 2pp

Record details

Prospective Grant of Exclusive License: Development of Anti-Angiogenesis Cancer Therapeutics Targeting Adrenomedullin or Proadrenomedullin N-Terminal 20 Peptide (PAMP); Federal Register Extracts

• Source: Government Press Releases (USA), August 31, 2009, 5pp

Record details

Bioactive Adrenomedullin, Measured with Sphingotec's bio-ADM(R) Assay Plays a Key Role in Septic Shock Patients as Top-Line Results of AdrenOSS-2 Phase II Study Indicate

• Source: TheNewswire.ca, February 24, 2020, 4pp

Record details

Bioactive Adrenomedullin, Measured with Sphingotec's bio-ADM(R) Assay Plays a Key Role in Septic Shock Patients as Top-Line Results of AdrenOSS-2 Phase II Study Indicate

• Source: ACCESSWIRE (British Columbia, Canada), February 24, 2020, 4pp

Record details

Prospective Grant of Exclusive License: Development of Anti-Angiogenesis Cancer Therapeutics Targeting Adrenomedullin or Proadrenomedullin N-Terminal 20 Peptide (PAMP); ACTION: Notice.

• Source: Federal Register (USA), August 29, 2009, 5pp

Record details

Adrenomed AG Seeks Patent for Method of Modulating the Activity of Adrenomedullin in a Subject in Need of Therapeutic Intervention for Organ Dysfunction or Organ Failure Associated with Adrenomedullin (ADM) Activity by Administering an Anti-Adrenomedullin (ADM) Antibody or an Anti-ADM Fragment to the Subject

• Source: Global IP News (India), March 29, 2019 Pharmaceutical Patent News, 3pp

Record details

Adrenomed AG Files Patent Application for Anti Adrenomedullin Antibody or Anti ADM Antibody Fragment or an Anti ADM Non Ig Scaffold for Use in Therapy

• Source: Indian Patents News (India), May 27, 2015 News, 2pp

Record details

Adrenomedullin Safe to Treat Ischemic Stroke, May Lead to Improved Outcomes

• Authors : By:Marco Meglio

• Source: Neurology Live (USA), February 7, 2024 News, 3pp

Record details

United States Patent for Adrenomedullin Assays and Methods for Determining Mature Adrenomedullin Issued to Sphingotec GmbH

• Source: Global IP News (India), August 18, 2023 Measurement & Testing Patent News, 2pp

Record details

The Feinstein Institute for Medical Research Files United States Patent Application for Adrenomedullin and Adrenomedullin Binding Protein for Ischemia/Reperfusion Treatment

• Source: Global IP News (India), November 20, 2014 Pharmaceutical Patent News, 2pp

Record details